Novavax (NVAX) Stock Soars 16% After an Analyst Rating Change
Novavax shares rose 15.8% as MT Newswires reported: BofA Adjusts Price Target on Novavax to $8 From $7, Keeps Underperform Rating
GTA Research Desk ·
TICKER
NVAX news & analysis
Novavax Inc. · $12.75 +15.80%
FREE NEWSLETTER
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.